躯体形式障碍患者躯体症状自评量表与SCL-90躯体化因子的相关性

Correlation analysis between the somato symptom self-rating scale and the somatization subscale of SCL-90 of SFD patients

目的探讨躯体症状自评量表(SSS)与症状自评量表(SCL-90)躯体化因子是否存在相关性。方法收集符合《精神障碍诊断与统计手册(第4版)》(DSM-IV)诊断标准的躯体化障碍和未分化型躯体形式障碍患者25例,采用自制一般情况调查表、SSS和SCL-90躯体化因子进行记录和评定,将受试者SCL-90躯体化因子评分与中国常模进行比较,分析SCL-90躯体化因子和SSS的相关性。结果受试者SCL-90躯体化因子评分高于中国常模水平[(12.28±7.63)分vs.(1.37±0.48)分,t=7.15,P<0.01];躯体化严重程度指数(SSI)和症状数分别为(154.04±38.97)分和(18.0±13.0),SCL-90躯体化因子评分与SSS中的SSI和症状数均呈正相关(r=0.750,0.730,P均<0.01)。结论 SSS可作为评估SFD的工具,是SCL-90躯体化因子的补充。

Objective To explore if there is any correlation between the Somato Symptom Self - rating Scale （ SSS） and thesomatization subscale of SCL - 90. Methods A total of 25 subjects who met the criterion for somatization disorder （ SD） andundifferentiated somatization disorder（ USD） according to the Diagnostic and Statistical Manual of Mental Disorders Fourth edition（DSM-IV ） were enrolled. A self - designed general questionnaire was adopted to collect the demographic and clinical data, and the SSStogether with the somatization subscale of SCL - 90 were employed to evaluate the somatization severity and a correlation was testedbetween them. The somatization subscale of SCL - 90 and the Chinese norm were also compared. Results The subjects exhibitedsignificantly higher scores for the somatization subscale of SCL -9 0 than that in the Chinese norm[（ 12. 28 ± 7. 63 ） vs. （ 1. 37 ± 0. 48 ） ,艺=7. 15,P 〈0.01]. The Somatization Severity Index（SSI） and the numbers of symptoms in SSS were （154.04 ±38.97） and （18.0 ±13.0）respectively. The scatterplot and correlation analysis showed that the socres for somatization subscale of SCL - 90 had a tendency ofpositive correlation with SSI and number of sysmptoms （r =0. 750, 0. 730, P 〈 0. 01 ） . Conclusion SSS is an important scale andsupplement for somatization subscale of SCL -90 to evaluate somatoform disorder.